Gene therapy for prostate cancer

Author： Shalev M.   Thompson T.C.   Kadmon D.   Ayala G.   Kernen K.   Miles B.J.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.57, Iss.1, 2001-01, pp. : 8-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient Selection for Therapy in Prostate Cancer

By David Crawford E.  

European Urology Supplements, Vol. 1, Iss. 2, 2002-05 ,pp. : 2-6

Elsevier

Access to resources Recommend Favorite

Osteocalcin Gene HindIII C/T Polymorphism Is a Biomarker for Prostate Cancer and Responsiveness to Hormone Therapy

By Wu H.-C.   Lin C.-C.   Chen W.-C.   Chen H.-Y.   Tsai F.-J.  

European Urology, Vol. 43, Iss. 2, 2003-02 ,pp. : 197-200

Elsevier

Access to resources Recommend Favorite

Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer - experimental models and clinical results

By Atkinson G.   Hall S.J.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1098-1104

Elsevier

Access to resources Recommend Favorite

Hormonal therapy for prostate cancer: primum non nocere

By Milbank A.J.   Dreicer R.   Klein E.A.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 738-741

Elsevier

Access to resources Recommend Favorite

Newer approaches to androgen deprivation therapy in prostate cancer

By Pitts W.R.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 882-882

Elsevier

Access to resources Recommend Favorite